Overview

Estrogen and Graft Atherosclerosis Research Trial (EAGER)

Status:
Completed
Trial end date:
2002-07-01
Target enrollment:
Participant gender:
Summary
To determine if postmenopausal hormone replacement therapy in women following coronary bypass surgery would reduce the occurrence of graft occlusion and delay the development of graft atherosclerosis.
Phase:
Phase 3
Details
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Estrogens
Hormones
Medroxyprogesterone
Medroxyprogesterone Acetate